GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Pharmaniaga Bhd (XKLS:7081) » Definitions » Cash-to-Debt

Pharmaniaga Bhd (XKLS:7081) Cash-to-Debt : 0.05 (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Pharmaniaga Bhd Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Pharmaniaga Bhd's cash to debt ratio for the quarter that ended in Sep. 2024 was 0.05.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Pharmaniaga Bhd couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2024.

The historical rank and industry rank for Pharmaniaga Bhd's Cash-to-Debt or its related term are showing as below:

XKLS:7081' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02   Med: 0.05   Max: 0.16
Current: 0.05

During the past 13 years, Pharmaniaga Bhd's highest Cash to Debt Ratio was 0.16. The lowest was 0.02. And the median was 0.05.

XKLS:7081's Cash-to-Debt is ranked worse than
91.74% of 109 companies
in the Medical Distribution industry
Industry Median: 0.79 vs XKLS:7081: 0.05

Pharmaniaga Bhd Cash-to-Debt Historical Data

The historical data trend for Pharmaniaga Bhd's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Pharmaniaga Bhd Cash-to-Debt Chart

Pharmaniaga Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 0.06 0.06 0.05 0.11

Pharmaniaga Bhd Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.11 0.07 0.06 0.05

Competitive Comparison of Pharmaniaga Bhd's Cash-to-Debt

For the Medical Distribution subindustry, Pharmaniaga Bhd's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaniaga Bhd's Cash-to-Debt Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Pharmaniaga Bhd's Cash-to-Debt falls into.



Pharmaniaga Bhd Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Pharmaniaga Bhd's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Pharmaniaga Bhd's Cash to Debt Ratio for the quarter that ended in Sep. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmaniaga Bhd  (XKLS:7081) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Pharmaniaga Bhd Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Pharmaniaga Bhd's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaniaga Bhd Business Description

Traded in Other Exchanges
N/A
Address
No. 7, Lorong Keluli 1B, Kawasan Perindustrian Bukit Raja Selatan, Seksyen 7, Shah Alam, SGR, MYS, 40000
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices, sales and marketing as well as the distribution of medical products and hospital equipment. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing, and Indonesia. Maximum revenue is generated by the logistics and distribution segment. It derives revenue from Malaysia, Indonesia, and Other countries, of which key revenue is derived from Malaysia.

Pharmaniaga Bhd Headlines

No Headlines